Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Cost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

Bespoke Extracts (BSPK) Cost of Revenue (2018 - 2025)

Bespoke Extracts' Cost of Revenue history spans 8 years, with the latest figure at $233770.0 for Q3 2025.

  • On a quarterly basis, Cost of Revenue rose 43.88% to $233770.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $751352.0, a 26.75% increase, with the full-year FY2024 number at $664517.0, up 50.24% from a year prior.
  • Cost of Revenue hit $233770.0 in Q3 2025 for Bespoke Extracts, up from $193054.0 in the prior quarter.
  • Over the last five years, Cost of Revenue for BSPK hit a ceiling of $233770.0 in Q3 2025 and a floor of -$46431.0 in Q4 2022.
  • Historically, Cost of Revenue has averaged $89824.2 across 5 years, with a median of $100411.0 in 2023.
  • Biggest five-year swings in Cost of Revenue: dropped 8.94% in 2021 and later surged 224515.38% in 2023.
  • Tracing BSPK's Cost of Revenue over 5 years: stood at $1864.0 in 2021, then plummeted by 2590.93% to -$46431.0 in 2022, then surged by 316.26% to $100411.0 in 2023, then soared by 71.44% to $172148.0 in 2024, then skyrocketed by 35.8% to $233770.0 in 2025.
  • Business Quant data shows Cost of Revenue for BSPK at $233770.0 in Q3 2025, $193054.0 in Q2 2025, and $152380.0 in Q1 2025.